74
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Multifunctional biomolecule nanostructures for cancer therapy

      review-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Biomolecule-based nanostructures are inherently multifunctional and harbour diverse biological activities, which can be explored for cancer nanomedicine. The supramolecular properties of biomolecules can be precisely programmed for the design of smart drug delivery vehicles, enabling efficient transport in vivo, targeted drug delivery and combinatorial therapy within a single design. In this Review, we discuss biomolecule-based nanostructures, including polysaccharides, nucleic acids, peptides and proteins, and highlight their enormous design space for multifunctional nanomedicines. We identify key challenges in cancer nanomedicine that can be addressed by biomolecule-based nanostructures and survey the distinct biological activities, programmability and in vivo behaviour of biomolecule-based nanostructures. Finally, we discuss challenges in the rational design, characterization and fabrication of biomolecule-based nanostructures, and identify obstacles that need to be overcome to enable clinical translation.

          Abstract

          Multifunctional nanostructures are explored for smart cancer nanomedicine. This Review discusses nanostructures made of biomolecules, including polysaccharides, nucleic acids, peptides and proteins, which are inherently multifunctional and allow the targeting and delivery of cancer drugs to tumour tissue.

          Related collections

          Most cited references254

          • Record: found
          • Abstract: found
          • Article: found

          Hallmarks of Cancer: The Next Generation

          The hallmarks of cancer comprise six biological capabilities acquired during the multistep development of human tumors. The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease. They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis. Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions. Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metabolism and evading immune destruction. In addition to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment." Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer. Copyright © 2011 Elsevier Inc. All rights reserved.
            • Record: found
            • Abstract: found
            • Article: not found

            mRNA vaccines — a new era in vaccinology

            mRNA vaccines represent a promising alternative to conventional vaccine approaches because of their high potency, capacity for rapid development and potential for low-cost manufacture and safe administration. However, their application has until recently been restricted by the instability and inefficient in vivo delivery of mRNA. Recent technological advances have now largely overcome these issues, and multiple mRNA vaccine platforms against infectious diseases and several types of cancer have demonstrated encouraging results in both animal models and humans. This Review provides a detailed overview of mRNA vaccines and considers future directions and challenges in advancing this promising vaccine platform to widespread therapeutic use.
              • Record: found
              • Abstract: not found
              • Article: not found

              Analysis of nanoparticle delivery to tumours

                Author and article information

                Contributors
                niegj@nanoctr.cn
                Journal
                Nat Rev Mater
                Nat Rev Mater
                Nature Reviews. Materials
                Nature Publishing Group UK (London )
                2058-8437
                19 May 2021
                : 1-18
                Affiliations
                [1 ]GRID grid.419265.d, ISNI 0000 0004 1806 6075, CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, China, ; Beijing, China
                [2 ]GRID grid.410726.6, ISNI 0000 0004 1797 8419, Center of Materials Science and Optoelectronics Engineering, , University of Chinese Academy of Sciences, ; Beijing, China
                [3 ]GBA Research Innovation Institute for Nanotechnology, Guangdong, China
                [4 ]GRID grid.207374.5, ISNI 0000 0001 2189 3846, Henan Institute of Advanced Technology, , Zhengzhou University, ; Zhengzhou, China
                Author information
                http://orcid.org/0000-0002-2291-532X
                http://orcid.org/0000-0001-9396-2345
                http://orcid.org/0000-0001-5040-9793
                Article
                315
                10.1038/s41578-021-00315-x
                8132739
                34026278
                89eee066-4b43-4fa7-bed4-8fb6774e382e
                © Springer Nature Limited 2021

                This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

                History
                : 6 April 2021
                Categories
                Review Article

                nanotechnology in cancer,cancer therapy
                nanotechnology in cancer, cancer therapy

                Comments

                Comment on this article

                Related Documents Log